✦ LIBER ✦

Treatment of Exudative Age-Related Macular Degeneration with a Designed Ankyrin Repeat Protein that Binds Vascular Endothelial Growth Factor: a Phase I/II Study

✍ Scribed by Souied, Eric H.; Devin, François; Mauget-Faÿsse, Martine; Kolář, Petr; Wolf-Schnurrbusch, Ute; Framme, Carsten; Gaucher, David; Querques, Giuseppe; Stumpp, Michael T.; Wolf, Sebastian

Book ID: 124104427
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 554 KB
Volume: 158
Category: Article
ISSN: 0002-9394
DOI: 10.1016/j.ajo.2014.05.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Diabetic Macular Edema With

Treatment of Diabetic Macular Edema With a Designed Ankyrin Repeat Protein That Binds Vascular Endothelial Growth Factor: A Phase I/II Study

✍ Campochiaro, Peter A.; Channa, Roomasa; Berger, Brian B.; Heier, Jeffrey S.; Bro 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 950 KB

A Phase 1 Study of KH902, a Vascular End

A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration

✍ Ming Zhang; Junjun Zhang; Mi Yan; Delun Luo; Wenjin Zhu; Peter K. Kaiser; De-Cha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 873 KB

Usefulness of a Commercial Hospital Clai

Usefulness of a Commercial Hospital Claims Database to Identify Current Anti-Vascular Endothelial Growth Factor Treatment Patterns in Patients with Exudative Age-Related Macular Degeneration in Japan

✍ Narimatsu, A.; Adachi, K.; Wang, E.C.Y. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB